Amais Ahmad

IMI - Oral biopharmaceutics tools project - Evaluation of bottom-up PBPK prediction success part 4: Prediction accuracy and software comparisons with improved data and modelling strategies.

M. Jamei, L. Aarons, M. Bolger, 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Pharmacokinetic-Pharmacodynamic Model To Evaluate Intramuscular Tetracycline Treatment Protocols To Prevent Antimicrobial Resistance in Pigs

L. Christiansen, N. Toft, L. Matthews, 2014, Antimicrobial Agents and Chemotherapy.

Application of the Nested Enzyme‐Within‐Enterocyte (NEWE) Turnover Model for Predicting the Time Course of Pharmacodynamic Effects

A. Darwich, A. Rostami-Hodjegan, H. Takita, 2020, CPT: pharmacometrics & systems pharmacology.

Modeling the growth dynamics of multiple Escherichia coli strains in the pig intestine following intramuscular ampicillin treatment

L. Christiansen, N. Toft, L. Matthews, 2016, BMC Microbiology.

Pharmacodynamic modelling of in vitro activity of tetracycline against a representative, naturally occurring population of porcine Escherichia coli

L. Christiansen, N. Toft, L. Matthews, 2015, Acta Veterinaria Scandinavica.

Physiological‐based pharmacokinetic modeling trends in pharmaceutical drug development over the last 20‐years; in‐depth analysis of applications, organizations, and platforms

Amin Rostami-Hodjegan, Eman El-Khateeb, Susan Burkhill, 2020, Biopharmaceutics & drug disposition.

Multistrain models predict sequential multidrug treatment strategies to result in less antimicrobial resistance than combination treatment

L. Christiansen, N. Toft, L. Matthews, 2016, BMC Microbiology.

Population pharmacokinetic modeling and simulation to support qualification of pyridoxic acid as endogenous biomarker of OAT1/3 renal transporters

A. Galetin, K. Ogungbenro, A. Rostami-Hodjegan, 2021, CPT: pharmacometrics & systems pharmacology.